Impaired regeneration and no amelioration with aldose reductase inhibitor in crushed unmyelinated nerve fibers of diabetic rats

NeuroReport

Volumn 10, Issue 11, 1999, Pages 2405-2409

  Yasuda, Hitoshi ^a   Terada, Masahiko ^a   Taniguchi, Yuzo ^b   Sasaki, Teiji ^a   Maeda, Kengo ^a   Haneda, Masakazu ^a   Kashiwagi, Atsunori ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Biol Res Ctr for Protect of E   (Japan)

Author keywords

Aldose reductase inhibitor; Crush; Regeneration; Unmyelinated nerve fiber

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; STREPTOZOCIN; TOLRESTAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; MALE; NERVE CRUSH; NERVE REGENERATION; NONHUMAN; NONMYELINATED NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0033516945     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199908020-00034     Document Type: Article

References (25)

1. 1. Gabby KH. N Engl J Med 288, 831-836 (1973).
2. 2. Brownlee M, Vlassara H and Cerami A. Ann Intern Med 101, 527-537 (1984).
3. 3. Cameron NE and Cotter NIA. Diabetes Metab Rev 10, 189-224 (1994).
4. 4. Yasuda H and Dyck PJ. Neurology 37, 20-28 (1987).
5. 5. Pfeifer MA and Schumer MP. Diabetes 44, 1355-1361 (1995).
6. 6. Longo FM, Powell HC, Lebeau J et al. Muscle Nerve 9, 385-393 (1986).
7. 7. Ekstrom PA and Tomlinson DR. J Neurol Sci 93, 231-237 (1989).
8. 8. Triban C, Guidolin D and Fabris M, Diabetes 38, 1012-1022 (1989).
9. 9. Terada M, Yasuda H. Kikkawa R and Shigela Y. Metabolism 45, 1189-1195 (1996).
10. 10. Apfel SC, Arezzo JC, Brownlee M et al. Brain Res 634, 7-12 (1994).
11. 11. Zhuang HX, Exp Neurol 140, 198-205 (1996).
12. 12. Apfel SC, Kessler JA, Adomato BT. et al. Neurology 51, 695-702 (1998).
13. 13. Pfeifer NIA, Schumer MP and Galber DA. Diabetes 46 (suppl. 2), S82-S89 (1997).
14. 14. Sima AAF, Bril V, Nathasisi V et al. N Engl J Med 319,548-555 (1988).
15. 15. Karnijo M, Merry AC, Akdes G et al. J Diabet Compl 10, 183-191(1996).
16. 16. Ohi T, Saita K, Furukawa S et al. Exp Neurol 151, 215-230 (1995).
17. 17. Simonati A, Rizzuto N and Cavanagh JB. Acta Neuropathol 39, 216-224 (1983).
18. 18. Bray GM, Aguayo AJ and Martin JB. Acta Neuropathol 26, 345-354 (1973).
19. 19. Bray GM and Aguayo AJ. J Anal 117, 517-529 (1976).
20. 20. Heumann R, Lindhohn D, Bandtlow C et al. Proc Natl Acad Sci USA 84, 8735-8739 (1987).
21. 21. Verkade P, Oestreicher AB, Verkleij AJ and Gispen WH, J Comp Neurol 356,433-443 (1995).
22. 22. Maeda K, Femyhough P and Tomlinson DR. Mol Brain Res 37, 166-174 (1996).
23. 23. Saito H, Sango K, Horie H et al. NeuroReport 10, 1-4 (1999).
24. 24. Chakrabarti S, Sima AAF, Nakjima T et al. Diabetologia 30, 244-251 (1987).
25. 25. Wong E, Mizisia AP, Garrett RS et al. J Neurochem 58, 2212-2220 (1992).